1. Home
  2. CBSH vs RGEN Comparison

CBSH vs RGEN Comparison

Compare CBSH & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CBSH
  • RGEN
  • Stock Information
  • Founded
  • CBSH 1865
  • RGEN 1981
  • Country
  • CBSH United States
  • RGEN United States
  • Employees
  • CBSH N/A
  • RGEN N/A
  • Industry
  • CBSH Major Banks
  • RGEN Medical/Dental Instruments
  • Sector
  • CBSH Finance
  • RGEN Health Care
  • Exchange
  • CBSH Nasdaq
  • RGEN Nasdaq
  • Market Cap
  • CBSH 8.7B
  • RGEN 8.0B
  • IPO Year
  • CBSH N/A
  • RGEN N/A
  • Fundamental
  • Price
  • CBSH $63.30
  • RGEN $118.10
  • Analyst Decision
  • CBSH Hold
  • RGEN Buy
  • Analyst Count
  • CBSH 6
  • RGEN 11
  • Target Price
  • CBSH $66.17
  • RGEN $169.33
  • AVG Volume (30 Days)
  • CBSH 771.5K
  • RGEN 706.5K
  • Earning Date
  • CBSH 07-16-2025
  • RGEN 07-29-2025
  • Dividend Yield
  • CBSH 1.72%
  • RGEN N/A
  • EPS Growth
  • CBSH 17.79
  • RGEN N/A
  • EPS
  • CBSH 4.03
  • RGEN N/A
  • Revenue
  • CBSH $1,643,891,000.00
  • RGEN $650,429,000.00
  • Revenue This Year
  • CBSH $8.42
  • RGEN $14.06
  • Revenue Next Year
  • CBSH $9.11
  • RGEN $14.33
  • P/E Ratio
  • CBSH $15.88
  • RGEN N/A
  • Revenue Growth
  • CBSH 4.97
  • RGEN 4.88
  • 52 Week Low
  • CBSH $52.69
  • RGEN $102.97
  • 52 Week High
  • CBSH $72.75
  • RGEN $182.52
  • Technical
  • Relative Strength Index (RSI)
  • CBSH 48.61
  • RGEN 39.56
  • Support Level
  • CBSH $64.03
  • RGEN $123.34
  • Resistance Level
  • CBSH $66.35
  • RGEN $135.57
  • Average True Range (ATR)
  • CBSH 1.25
  • RGEN 4.62
  • MACD
  • CBSH 0.20
  • RGEN -0.33
  • Stochastic Oscillator
  • CBSH 43.62
  • RGEN 0.65

About CBSH Commerce Bancshares Inc.

Commerce Bancshares Inc operates as the bank holding company for Commerce Bank. The bank is engaged in the general banking business, providing a broad range of retail, mortgage banking, corporate, investment, trust, and asset management products and services to individuals, businesses, and municipalities. It operates through three segments: Consumer, Commercial, and Wealth. The Commercial segment provides corporate lending, payment solutions, leasing, international services, and business banking. The Consumer segment covers retail banking, mortgages, installment lending, and card services. The Wealth segment offers trust and estate planning, brokerage, and investment management services.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: